In conclusion, a fixed-dose (1 mg) GST using a peak GH cutoff of < 3 ng/mL or < 1 ng/mL seems useful for screening for GHD in adults and late adolescents with PWS. Here, GH1 is linked to Prader-Willi syndrome.